BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33807284)

  • 1. Time-Restricted Eating for 12 Weeks Does Not Adversely Alter Bone Turnover in Overweight Adults.
    Lobene AJ; Panda S; Mashek DG; Manoogian ENC; Hill Gallant KM; Chow LS
    Nutrients; 2021 Mar; 13(4):. PubMed ID: 33807284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial.
    Papageorgiou M; Biver E; Mareschal J; Phillips NE; Hemmer A; Biolley E; Schwab N; Manoogian ENC; Gonzalez Rodriguez E; Aeberli D; Hans D; Pot C; Panda S; Rodondi N; Ferrari SL; Collet TH
    Obesity (Silver Spring); 2023 Feb; 31 Suppl 1(Suppl 1):85-95. PubMed ID: 36239695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials.
    Zibellini J; Seimon RV; Lee CM; Gibson AA; Hsu MS; Shapses SA; Nguyen TV; Sainsbury A
    J Bone Miner Res; 2015 Dec; 30(12):2168-78. PubMed ID: 26012544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Restricted Eating and Bone Health: A Systematic Review with Meta-Analysis.
    Fernández-Rodríguez R; Garrido-Miguel M; Bizzozero-Peroni B; Díaz-Goñi V; Rodríguez-Gutiérrez E; Guzmán-Pavón MJ; Meseguer-Henarejos AB; Torres-Costoso A
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-Restricted Eating Improves Quality of Life Measures in Overweight Humans.
    Crose A; Alvear A; Singroy S; Wang Q; Manoogian E; Panda S; Mashek DG; Chow LS
    Nutrients; 2021 Apr; 13(5):. PubMed ID: 33922683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
    Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
    Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Restricted Eating Effects on Body Composition and Metabolic Measures in Humans who are Overweight: A Feasibility Study.
    Chow LS; Manoogian ENC; Alvear A; Fleischer JG; Thor H; Dietsche K; Wang Q; Hodges JS; Esch N; Malaeb S; Harindhanavudhi T; Nair KS; Panda S; Mashek DG
    Obesity (Silver Spring); 2020 May; 28(5):860-869. PubMed ID: 32270927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [PHASIC CHANGES OF BONE MASS, BONE TURNOVER MARKERS, AND ESTROGEN LEVELS AT DIFFERENT TIME POINTS AFTER GLUCOCORTICOID INTERVENTION AND THEIR CORRELATION IN RATS].
    Ren H; Shen G; Jiang X; Liang D; Tang J; Cui J; Lin S; Zhuang H; Yang Z; Zhang S; Yao Z
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Mar; 29(3):307-14. PubMed ID: 26455196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-weekly teriparatide improves lumbar spine BMD independent of pre-treatment BMD and bone turnover marker levels.
    Takada J; Yoshimura T; Uzawa T
    J Bone Miner Metab; 2021 May; 39(3):484-493. PubMed ID: 33389132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis.
    Bauer DC; Garnero P; Bilezikian JP; Greenspan SL; Ensrud KE; Rosen CJ; Palermo L; Black DM
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1370-5. PubMed ID: 16449339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of orlistat on bone turnover and body composition.
    Gotfredsen A; Westergren Hendel H; Andersen T
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1154-60. PubMed ID: 11486790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
    Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disordered-eating attitudes in relation to bone mineral density and markers of bone turnover in overweight adolescents.
    Schvey NA; Tanofsky-Kraff M; Yanoff LB; Checchi JM; Shomaker LB; Brady S; Savastano DM; Ranzenhofer LM; Yanovski SZ; Reynolds JC; Yanovski JA
    J Adolesc Health; 2009 Jul; 45(1):33-9. PubMed ID: 19541247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes - randomized controlled trial.
    Maagensen H; Larsen JR; Jørgensen NR; Fink-Jensen A; Vilsbøll T
    Psychiatry Res; 2021 Feb; 296():113670. PubMed ID: 33373806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa.
    Giollo A; Idolazzi L; Caimmi C; Fassio A; Bertoldo F; Dalle Grave R; El Ghoch M; Calugi S; Bazzani PV; Viapiana O; Rossini M; Gatti D
    Int J Eat Disord; 2017 Sep; 50(9):1041-1049. PubMed ID: 28593655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.
    Tangpricha V; Luo M; Fernández-Estívariz C; Gu LH; Bazargan N; Klapproth JM; Sitaraman SV; Galloway JR; Leader LM; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2006; 30(6):480-6. PubMed ID: 17047171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study.
    Duggan SN; Purcell C; Kilbane M; O'Keane M; McKenna M; Gaffney P; Ridgway PF; Boran G; Conlon KC
    Am J Gastroenterol; 2015 Feb; 110(2):336-45. PubMed ID: 25623657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density and biochemical markers of bone turnover in healthy elderly men and women.
    Krall EA; Dawson-Hughes B; Hirst K; Gallagher JC; Sherman SS; Dalsky G
    J Gerontol A Biol Sci Med Sci; 1997 Mar; 52(2):M61-7. PubMed ID: 9060971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
    J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.